What does NewCardio, Inc. do?

NewCardio, Inc. (NWCI) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is NWCI's market cap?

NewCardio, Inc. (NWCI) has a market capitalization of approximately $3,315, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does NWCI pay a dividend?

No — NewCardio, Inc. (NWCI) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

NewCardio, Inc. (NWCI) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

NWCI

NewCardio, Inc.

OTC·Medical, Devices · Healthcare

$0.00$0.00+0.00%

Market cap$3.32K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−94.29%CAGR −43.59%

Select date range

FromTo

Jan 4, 2008Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

NWCI does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateApr 1

Last Report DateNov 15

Reported vs Estimate−$0.07 vs −$0.08

Earnings Surprise+12.5%

FinancialsFinancials Tab

Revenue$238.58K

Net Income−$8.84M

Net Margin−3,705.2%

Operating Cash Flow−$2.57M

Capital Expenditures$75.70K

Free Cash Flow−$2.65M

Return on Equity—

Return on Invested Capital122.5%

Net Debt$3.89M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for NWCI and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how NWCI's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NWCI and 80,000+ other tickers.

About NewCardio, Inc.

NewCardio, Inc. is a company dedicated to cardiac diagnostics and related services. Its primary objective is the research, creation, and market introduction of exclusive software platform technologies. These innovations are designed for two main applications: the non-invasive diagnosis and continuous monitoring of cardiovascular diseases (CVD), and the assessment of cardiac safety for experimental drugs. The company's underlying technology analyzes the heart's electrical activity in real-time and in three dimensions, using data gathered from the body's surface via standard 12-lead…

CEO: Jess Emery Jones
Sector: Healthcare
Industry: Medical - Devices
Exchange: OTC
Employees: 10
Website: www.newcardio.com

Peers

Peers Tab

EVARF

Lombard Medical, Inc.

Cap

$2.8K

BBAL

New York Health Care, Inc.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About NWCI

What does NewCardio, Inc. do?: NewCardio, Inc. (NWCI) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is NWCI's market cap?: NewCardio, Inc. (NWCI) has a market capitalization of approximately $3,315, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does NWCI pay a dividend?: No — NewCardio, Inc. (NWCI) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is NWCI profitable?: NewCardio, Inc. (NWCI) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.